161 related articles for article (PubMed ID: 21374644)
1. In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
Sorragi Cde L; Shishido SM; Lemos ME; Marcondes S; Antunes E; Krieger MH
Cell Biochem Funct; 2011 Apr; 29(3):207-14. PubMed ID: 21374644
[TBL] [Abstract][Full Text] [Related]
2. Solid films of blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for topical S-nitrosoglutathione and nitric oxide release.
Seabra AB; da Rocha LL; Eberlin MN; de Oliveira MG
J Pharm Sci; 2005 May; 94(5):994-1003. PubMed ID: 15793801
[TBL] [Abstract][Full Text] [Related]
3. Poly(vinyl alcohol) and poly(vinyl pyrrolidone) blended films for local nitric oxide release.
Seabra AB; De Oliveira MG
Biomaterials; 2004 Aug; 25(17):3773-82. PubMed ID: 15020153
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosoglutathione decreases inflammation and bone resorption in experimental periodontitis in rats.
de Menezes AM; de Souza GF; Gomes AS; de Carvalho Leitão RF; Ribeiro Rde A; de Oliveira MG; de Castro Brito GA
J Periodontol; 2012 Apr; 83(4):514-21. PubMed ID: 21910597
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
6. Antithrombogenic polynitrosated polyester/poly(methyl methacrylate) blend for the coating of blood-contacting surfaces.
Seabra AB; da Silva R; de Souza GF; de Oliveira MG
Artif Organs; 2008 Apr; 32(4):262-7. PubMed ID: 18370938
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
8. cGMP-independent inhibition of integrin alphaIIbbeta3-mediated platelet adhesion and outside-in signalling by nitric oxide.
Oberprieler NG; Roberts W; Riba R; Graham AM; Homer-Vanniasinkam S; Naseem KM
FEBS Lett; 2007 Apr; 581(7):1529-34. PubMed ID: 17376438
[TBL] [Abstract][Full Text] [Related]
9. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
Prasad R; Giri S; Nath N; Singh I; Singh AK
Glia; 2007 Jan; 55(1):65-77. PubMed ID: 17019693
[TBL] [Abstract][Full Text] [Related]
10. Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent.
Young DV; Serebryanik D; Janero DR; Tam SW
Mol Cell Biol Res Commun; 2000 Jul; 4(1):32-6. PubMed ID: 11152625
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide releasing Tygon materials: studies in donor leaching and localized nitric oxide release at a polymer-buffer interface.
Joslin JM; Lantvit SM; Reynolds MM
ACS Appl Mater Interfaces; 2013 Oct; 5(19):9285-94. PubMed ID: 23957655
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.
Rosales MA; Silva KC; Duarte DA; de Oliveira MG; de Souza GF; Catharino RR; Ferreira MS; Lopes de Faria JB; Lopes de Faria JM
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2921-32. PubMed ID: 24699383
[TBL] [Abstract][Full Text] [Related]
13. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.
Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K
Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751
[TBL] [Abstract][Full Text] [Related]
14. Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.
Wu W; Gaucher C; Diab R; Fries I; Xiao YL; Hu XM; Maincent P; Sapin-Minet A
Eur J Pharm Biopharm; 2015 Jan; 89():1-8. PubMed ID: 25448077
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Activity and Cytotoxicity to Tumor Cells of Nitric Oxide Donor and Silver Nanoparticles Containing PVA/PEG Films for Topical Applications.
Rolim WR; Pieretti JC; Renó DLS; Lima BA; Nascimento MHM; Ambrosio FN; Lombello CB; Brocchi M; de Souza ACS; Seabra AB
ACS Appl Mater Interfaces; 2019 Feb; 11(6):6589-6604. PubMed ID: 30653288
[TBL] [Abstract][Full Text] [Related]
16. Construction and evaluation of nitric oxide generating vascular graft material loaded with organoselenium catalyst via layer-by-layer self-assembly.
An J; Chen S; Gao J; Zhang X; Wang Y; Li Y; Mikhalovsky S; Kong D; Wang S
Sci China Life Sci; 2015 Aug; 58(8):765-72. PubMed ID: 26014212
[TBL] [Abstract][Full Text] [Related]
17. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY
Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396
[TBL] [Abstract][Full Text] [Related]
19. [In vitro effects of cAMP- and cGMP-stimulating drugs on the relaxation of the prostate smooth muscle tissue contraction induced by endothelin-1].
Kediia G; Uckert S; Kediia M; Truss MC; Chigogidze T; Jonas U; Managadze LG
Georgian Med News; 2006 Feb; (131):7-13. PubMed ID: 16575120
[TBL] [Abstract][Full Text] [Related]
20. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
Vilahur G; Pena E; Padró T; Badimon L
Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
